ExodusPoint Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-266,329
Closed -$27.4M 1713
2025
Q4
$27M Buy
266,329
+191,023
+254% +$15.3M 0.21% 65
2025
Q3
$4.12M Buy
75,306
+9,605
+15% +$480K 0.04% 482
2025
Q2
$3.49M Buy
+65,701
New +$3.34M 0.03% 534
2025
Q1
Sell
-195,791
Closed -$11M 1623
2024
Q4
$11M Buy
195,791
+135,245
+223% +$8.42M 0.08% 247
2024
Q3
$4.12M Buy
+60,546
New +$3.42M 0.03% 490
2024
Q2
Sell
-203,378
Closed -$14M 1647
2024
Q1
$14M Sell
203,378
-16,685
-8% -$1.06M 0.11% 154
2023
Q4
$16.3M Buy
220,063
+97,743
+80% +$6.41M 0.11% 134
2023
Q3
$8.35M Buy
122,320
+104,842
+600% +$8.9M 0.08% 259
2023
Q2
$1.64M Buy
17,478
+3,916
+29% +$305K 0.01% 893
2023
Q1
$920K Sell
13,562
-44,730
-77% -$2.88M 0.01% 1167
2022
Q4
$2.89M Sell
58,292
-12,600
-18% -$515K 0.04% 516
2022
Q3
$2.3M Buy
+70,892
New +$2.92M 0.03% 738
2022
Q1
Sell
-12,639
Closed -$984K 2322
2021
Q4
$984K Buy
+12,639
New +$1.12M 0.01% 1083
2021
Q1
Sell
-4,018
Closed -$532K 2242
2020
Q4
$532K Buy
4,018
+2,933
+270% +$355K 0.01% 1210
2020
Q3
$111K Sell
1,085
-27,143
-96% -$2.34M ﹤0.01% 1578
2020
Q2
$2.45M Buy
+28,228
New +$2.26M 0.06% 350
2020
Q1
Sell
-2,385
Closed -$221K 1238
2019
Q4
$221K Sell
2,385
-515
-18% -$45.3K ﹤0.01% 1300
2019
Q3
$262K Buy
+2,900
New +$330K 0.01% 964
2019
Q2
Sell
-78,819
Closed -$6.83M 1173
2019
Q1
$6.83M Buy
+78,819
New +$6.71M 0.51% 28

Other funds holding EXAS

ExodusPoint Capital Management's EXAS Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 266,329 shares — an estimated $27.4M sold.

ExodusPoint Capital Management first reported a position in EXAS in Q1 2019 and held it in 19 quarters. The position peaked at $27M in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • ExodusPoint Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 266,329 Exact Sciences shares in Q1 2026, an estimated $27.4M.
  • ExodusPoint Capital Management first reported a position in Exact Sciences in Q1 2019 and held it in 19 quarters.
  • ExodusPoint Capital Management's Exact Sciences position peaked at $27M in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.